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CHAPTER I 
INTRODUCTION
The presence of protein-bound carbohydrate in the serum was 
recognized before the beginning of this century (1, 2). The major mono­
saccharide components of serum glycoproteins are galactose, mannose, 
glucosamine and sialic acid. Galactosamine and fucose are minor con­
stituents of some serum glycoproteins. These carbohydrates are widely 
distributed in all major serum protein fractions with the possible ex­
ception of serum albumin, but are particularly prominent in the a-globu- 
lin fractions.
It is well known that the concentration of the glycoprotein in 
human serum is greatly increased in a number of physiological and patho­
logical states (3). Very little is known at the present time about the 
metabolic alterations which lead to these changes. Our knowledge about 
the normal synthesis and destruction of glycoproteins in the animal body 
is also incomplete.
In the present investigation the mechanism of serum glycoprotein 
biosynthesis was studied in normal rats and in rats bearing Walker 256 
carcinosarcoma. D-Glucosamine-l-C-14 was utilized as a means of follow­
ing this biosynthetic process.
1
CHAPTER II
LITERATURE REVIEW
Since the work described in this dissertation includes studies 
on the biosynthesis of serum glycoprotein and the carbohydrate content of 
subcellular fractions in rat liver and Walker 256 carcinosarcoma, this 
section of the dissertation will review the studies concerned with the 
(1) biosynthesis of serum glycoprotein, and (2) cell fractionation and 
carbohydrate content of subcellular fractions in rat liver and tumor 
tissue.
Biosynthesis of Serum Glycoprotein 
Although the presence of protein-bound carbohydrate in the serum 
was recognized before 1900 (1, 2), the progress in this field beyond this 
phase was rather slow. Renewed interest in the study of these protein- 
bound carbohydrates in the sera was initiated by the finding of a sig­
nificant elevation of serum glycoproteins in various physiological and 
pathological states (3, 4, 5). Since the elevation of serum glycopro­
teins in several disease states is so prominent, efforts have been made 
by numerous investigators to explain the cause of elevated serum glyco­
proteins. A  number of hypotheses concerning the physiological mechanism 
that produces the elevation of serum glycoproteins in disease states have 
been proposed.
2
3Seibert, Seibert, Atno and Campbell (6) noted the prominent 
elevation of the (% 2-globulin levels in pathological processes involving 
tissue destruction, and proposed that elevations of glycoprotein above 
the normal level reflect the processes of tissue destruction. In support 
of the view that tissue destruction contributes directly to the serum 
glycoprotein level, Lustig and Nassau (7) found that venous blood con­
tained more glycoprotein than arterial blood. Catchpole (8) showed that 
connective tissue adjacent to transplanted tumors in mice contained more 
material with properties similar to seromucoid than did connective tissue 
remote from the tumor. He proposed that serum glycoproteins may arise 
as a result of the depolymerization of the ground substance of the con­
nective tissue with the release of solubilized components into the circu­
lation. In agreement with Catchpole's hypothesis, Engel (9) found that 
with the dissolution of bone following the administration of parathyroid 
hormone to rats, there was a pronounced increase in the seromucoid levels. 
It was presumed that the seromucoid was released as a result of the de­
polymerization of the ground substance of bone. Shetlar and his collabo­
rators (10, 11), observed that elevations of serum glycoproteins are fre­
quently associated with conditions in which tissue destruction is not 
pronounced and cell proliferations or protein synthesis is rapid. They 
suggested that an elevated serum glycoprotein level may reflect processes 
associated with tissue proliferation rather than with tissue destruction. 
Increased glycoprotein synthesis may be caused by either destruction or 
proliferation. The hypotheses mentioned above do not suggest where or 
how glycoproteins are synthesized in physiological and pathological states.
We are indebted to Whipple and his co-workers for their studies
4of the formation of plasma proteins. Their work indicates that most of 
the plasma proteins with the possjlble exception of 7-globulin were synthe­
sized by the liver (12, 13, 14). Miller and Bale (15) presented direct 
evidence for the dominant role of the liver in the biosynthesis of plasma 
proteins in a study of the isolated perfused rat liver.
Since the liver plays a dominant role in the plasma protein 
biosynthesis, it is natural for investigators to suggest that the liver 
is the organ responsible for glycoprotein synthesis. In 1949, Werner 
(16) concluded that the liver was the site of serum glycoprotein forma­
tion on the basis of experiments which showed that the concentration of 
serum protein-bound glucosamine increased in rabbits after bleeding.
This phenomenon did not occur if the liver had been damaged with phos­
phorus or benzene. Greenspan et al. (17, 18, 19, 20, 21) working on this 
problem observed that the serum glycoprotein level was lowered in 
patients with infectious hepatitis, homologous serum hepatitis or portal 
cirrhosis. On the bases of these observations, they suggested that the 
liver is involved in the synthesis of serum glycoprotein.
Studies of serum glycoprotein biosynthesis utilizing radioactive 
glucose as a tracer were made by Becker and Day (22) and Spiro (23) in 
rats and by Bostrüm, Rodin and Yamashina (24) in guinea pigs. In 1953, 
Becker and Day (22) first found that C-14 was present in the glucosamine 
isolated from the rats fed glucose-l-C-14. In 1959, Bostrom et al. (24) 
isolated radioactive ttj^-acid-glycoprotein from the plasma of guinea pigs 
at different times after intraperitoneal injection of glucose-U-C-14.
They found that the incorporation of radioactivity from glucose-U-C-14 
into a-j^-acid-glycoprotein reached a maximum approximately 24 hours after
5injection. The greatest incorporation of radioactivity was observed in 
the neutral sugar component of the carbohydrate moiety. They also noted 
that sialic acid and glucosamine were labelled. The results of Bostrom 
et a l . (24) only indicated that carbohydrates in plasma glycoproteins 
were synthesized from glucose. Their experimental results did not indi­
cate how and where the plasma glycoproteins were synthesized. In the 
study of the incorporation of radioactivity from glucose-U-C-14 into the 
protein-bound glucosamine of various tissues of the intact rat, Spiro 
(23) noted that liver and serum showed the most rapid synthesis of glucos­
amine from glucose. By measuring the specific radioactivity and total 
radioactivity of liver and serum protein-bound glucosamine in rats at 
varying time intervals after the injection of a tracer dose of glucose- 
U-C-14, Spiro was able to obtain evidence that serum glycoproteins are 
synthesized in the liver.
In 1961 Shetlar and his co-workers (25, 26) first utilized 
glucosamine-1-C-14 as a tracer to demonstrate that the radioactivity was 
rapidly taken up by rat liver and released to the serum as a protein- 
bound glucosamine without appreciable destruction. By measuring the 
changes of radioactivity in serum proteins and in the liver protein after 
intraperitoneal injection of glucosamine-1-C-14 into rats, Shetlar (25) 
found that the activity curve of bound glucosamine reached a peak more 
quickly in the liver than it did in the serum and suggested that a 
sizable fraction of the serum glycoproteins are synthesized by the liver. 
The result of this work was compatible with the work of Spiro (23) who 
used glucose-U-C-14 as a tracer. The work of Shetlar's group was con­
firmed in 1962 by Kohn, Winzler and Hoffmann (27) who reported the incor­
poration of D-glucosamine-l-C-14 into labeled trichloroacetic acid-
6precipitable glucosamine and sialic acid of the rat liver. In the same 
year, Shetlar and his co-workers also reported the incorporation of radio­
activity into various tissues after parenteral administration of glucos- 
amine-l-C-14 to the rats (28). Also in the same year, Sarcione (29) used 
a perfusion technique to demonstrate that the isolated rat liver incor­
porated glucose-U-C-14 into plasma glycoprotein. It was at this stage 
(January, 1963), the author joined Dr. Shetlar's group to undertake the 
studies on the mechanism of the biosynthesis of serum glycoprotein.
Since then, the following studies related to the glycoprotein biosynthe­
sis have appeared in the literature.
In 1963, Sarcione (30) reported the synthesis of Qji-acid glyco­
protein by the isolated rat liver perfused with D-glucose-U-C-l4 and L- 
leucine-U-C-14. Both glucose and leucine were incorporated into plasma 
Qj^-acid glycoprotein by perfused liver _in vitro.
In 1964, Shetlar, Capps and Hern (31) reported the incorporation 
of radioactive glucosamine into the serum proteins of intact rats and 
rabbits. They reported that when D-glucosamine-l-C-14 was administered 
to rats and rabbits by intraperitoneal injection, maximum radioactivity 
of the trichloroacetic acid soluble fraction was found in rat liver within 
30 minutes and in rabbit liver within 1 hour after the injection. Maxi­
mum protein-bound radioactivity in the serum was found at 3 hours for the 
rat and at 7 hours for the rabbit. The efficiency of the incorporation 
into serum proteins at the maximum level of radioactivity was 24% and 
28% of the administered dose for rats and rabbits, respectively. About 
22% of the bound radioactivity in serum was associated with sialic acid 
in the rat and most of the remaining 78% activity was associated with 
glucosamine. Negligible amounts of radioactivity were found in the 
hexoses.
7Macbeth, Bekesi, Sugden and Bice (32) also published a similar 
study in 1965. They reported that the administered glucosamine-1-C-14 
was present as bound hexosamine and N-acetylneuraminic acid in the serum 
glycoprotein and in various tissues of the intact rat. Glucosamine-1-C- 
14 was shown to be a precursor in the biosynthetic pathway of both 
protein-bound hexosamine and N-acetylneuraminic acid. From the experi­
ment using hepatectomized rats, the conclusion was made that the liver 
was the major, if not the sole, site of biosynthesis of serum glyco­
proteins in the normal rat.
In 1964, Robinson, Molnar and Winzler (33) reported that glucos- 
amine-l-C-14 administered intravenously to rats was rapidly converted 
to protein-bound components of liver microsomes and mitochondria and 
then released to the plasma without appreciable accumulation in the cyto­
plasmic protein of the liver. Molnar, Robinson and Winzler (34) showed 
that the incorporation of glucosamine-l-C-14 into rat liver and plasma 
protein was markedly inhibited by puromycin. By adding glucosamine- 
l-C-14 and galactose-l-C-14 into the perfusing blood to isolated rat 
liver i^ vitro, Sarcione (35, 36) found that the deoxycholate-soluble 
(membranous) protein fraction of microsomes was a major site of sugar 
incorporation. He reported virtually no incorporation of hexose into 
ribosomal proteins. In contrast to Sarcione's results Molnar, Robinson 
and Winzler (37) found a definite labeling of ribosomes, which reaches a 
maximum in specific radioactivity somewhat earlier than the microsomal 
membrane. Athineos, Kukral and Winzler (38) administered glucosamine- 
l-C-14 into normal and hepatectomized dogs, and found that cc^-acid glyco­
protein became highly labeled in normal dogs with almost all of the 
radioactivity residing in the glucosamine component, while the glyco­
8protein isolated from hepatectomized dogs was not radioactive and con­
cluded that the liver is the site of biosynthesis of Qj^-acid glycoprotein.
In 1965, Helgeland (39) re-examined the incorporation of glucos­
amine-l-C-14 into subcellular fractions of rat liver and reported that 
69% of the total radioactivity was associated with the ultrasonic extract 
of the microsomal pellet, 28% in the subsequent deoxycholate extract and 
3% associated with the ribosomes. Sinohara and Sky-Peck (40) failed to 
demonstrate in vitro incorporation of glucosamine-l-C-14 into the soluble 
ribonucleic acid of mouse liver. They found that during the course of 
glucosamine-l-C-14 incorporation into.the microsomal fraction in vivo 
by way of uridine diphosphate-N-acetylglucosamine, the soluble ribo­
nucleic acids isolated from the high-speed supernatant fraction of liver 
were not labeled. By using Ehrlich ascites carcinoma cells. Cook, Laico 
and Eylar (41) examined^ the incorporation of labeled glucosamine and amino 
acid into the smooth and rough endoplasmic reticulum. They found that 
the labeled hexosamine of microsomes was only associated with the mem­
brane, and not with the ribosomes. Molnar, Lutes and Winzler (42) and 
Molnar, Teegarden and Winzler (43) reported a rapid incorporation of 
glucosamine-l-C-14 into the trichloroacetic acid-insoluble fraction of 
Ehrlich ascites carcinoma cells. Among the subcellular fractions, the 
microsome was the one most highly labeled.
Fractionation of Subcellular Particles and 
Their Carbohydrate Content
Biochemical studies of the subcellular components have been 
achieved j?y isolating the particulate fractions from disrupted cells by 
differential centrifugation. This technique is mainly based on the as­
sumption that the particulate components of tissue homogenates have
9different sedimentation coefficients and densities. Obviously, the sedi­
mentation coefficients and densities are greatly affected by the size and 
shape.of the particle as well as the viscosity of the suspension. Much 
work has been done on establishing the scheme of the cell fractionation. 
The pioneer works were the study of Bensley and Hoerr (44) in 1934. They 
disrupted the cell membrane mechanically in a suitable medium and used 
the resulting homogenate for the isolation of mitochondria by means of 
differential centrifugation. A  few years later, Claude (45, 46, 47) 
subjected normal and tumor tissue homogenates in dilute electrolyte solu­
tion to differential centrifugation and obtained a fraction, after sedi­
mentation of the ordinary mitochondrial fraction, which was rich in ribo­
nucleic acid and phospholipids. He introduced a descriptive name, micro- 
some, i.e. "small bodies" to the newly found particle. The use of salt 
media did not yield morphologically intact mitochondria and often led to 
agglutination of the particles. An important step forward was made when 
Hogeboom, Schneider and Palade (48) introduced sucrose as a medium in the 
fractionation^procedure. Hypertonic sucrose (0.88 M) gave the morpho­
logically most satisfactory results. However, it was soon found that 
this high concentration of sucrose inhibits certain metabolic processes, 
and isotonic sucrose (0.25 M) was therefore substituted by Schneider (49). 
Beginning with Hogeboom's group (50, 51), the sucrose medium became the 
one most often used in tissue fractionation.
The identification of microsomes as fragments of the endoplasmic 
reticulum was achieved by Palade and Siekevitz (52, 53). They performed 
systematic electron-microscope study of intact rat liver, liver homogen­
ates, and isolated microsomes, as well as submicrosomal fractions prepared 
with deoxycholate. The morphological observations were correlated with
10
chemical analysis of the various fractions and it was found that the rat 
liver microsomes consist of "rough-surfaced" vesicles with small, dense 
particles attached to their outer surface and "smooth-surfaced" vesicles, 
devoid of such particles. Deoxycholate in a final concentration of 0.5% 
solubilized the membrane and the contents of the vesicles, but not the 
particles. This experiment also provided clear evidence that the micro­
somal vesicles are derived from the endoplasmic reticulum. The majority 
of components, the rough vesicles or rough tubules, are the result of 
fragmentation of the rough-surfaced endoplasmic reticulum, and the smooth 
vesicles originate, at least partly, from the region of the endoplasmic 
reticulum which lacks attached ribosomes.
By using the sucrose medium and the differential centrifugation 
described by Hogeboom, Schneider and Palade (48), De Duve found that acid 
phosphatase was detected in the microsomal fraction, but by using the 
modified technique of Novikoff, Podber, Ryan and Noe (54) or Tsuboi (55), 
the same enzyme was identified in the mitochondrial fraction. This in­
consistent localization of an enzyme led De Duve, Pressman, Gianetto, 
Wattiaux and Appelmans (56) to establish a modified scheme by which they 
were able to fractionate, besides mitochondria and microsomes, one group 
of new particles having the density between mitochondria and microsomes. 
These newly separated particles were named "lysosomes" by De Duve's group. 
Today the scheme described by De Duve et (56) is the one most widely 
used.
Although many papers have been published on the distribution of 
enzymic activities in various subcellular particles, very little work 
has been reported on the distribution of carbohydrate in these particles. 
In 1961, Wallach and Eyler (57) determined the distribution of sialic
11
acid in subcellular fractions of Ehrlich ascites carcinoma cells and re­
ported the following distribution: 69.5% in microsomes, 17.3% in mitochon­
dria, 13.6%, in supernatant and 3.2% in the nuclear fraction. In 1962, 
Patterson and Touster (58) determined the distribution of sialic acid in 
subcellular fractions of rat liver and found that sialic acid was distri­
buted throughout the cell, with the exception of the nuclear fraction.
The highest concentration was in the microsomal and supernatant fraction. 
They also found that the sialic acid in the supernatant fraction is in 
bound form as indicated by a negative thiobarbituric acid test prior to 
hydrolysis. In 1964, Yamashina, Isumi and Naka (59) studied the intra­
cellular distribution of hexosamine and sialic acid in rabbit liver.
They found that hexosamine and sialic acid in rabbit liver were local­
ized mainly in the microsomal and the mitochondrial fractions. No work 
can be found in the literature related to the analysis of neutral sugars 
in subcellular fractions.
CHAPTER III
MATERIALS AND METHODS
Preparation of Subcellular Fractions 
Male albino rats of the Holtzman strain (200-300 gm) were used. 
The animals, were fed with Rockland laboratory diet ^  libitum. Walker 
256 carcinosarcoma was carried in the subcutaneous tissue of the rats 7 
to 8 days. All animals were fasted for 24 hrs before sacrifice. The 
animals were exsanguinated from the abdominal aorta, and the livers were 
perfused situ with physiologic saline via the portal vein. Both liver 
and tumor tissues were fractionated by the procedures of De Duve et al. 
(56) with slight modifications. The tissues were homogenized in a 
Potter-Elvehjem type of horaogenizer in 5 volumes of 0.25 M  sucrose- 
0.001 M  EDTA (ethylenediaminetetraacetate). The homogenate was centri­
fuged at 1000 X g for 10 minutes in a Serval1 refrigerated centrifuge.
The sedimented fraction was saved for the preparation of nuclei, and 
the supernatant was centrifuged at 3300 X g for 10 minutes to obtain 
mitochondria. The resulting sediment was washed with 3 volumes of the 
sucrose-EDTA. solution to give the final mitochondrial fraction. A. 
small lysosomal-rich fraction was sedimented at 12,000 X g for 10 minutes 
and washed once with 3 volumes of sucrose-EDTA, solution. The microsomal 
fraction was sedimented at 105,000 X g for 60 minutes in a Spinco Model 
L ultracentrifuge. The nuclei were prepared from 1000 X g sediment by
12
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the method of Hogeboom, Schneider and Striebich (60). Sediment obtained 
from 1000 X g centrifugation was homogenized with 5 volumes of 2.2 M 
sucrose and centrifuged at 40,000 X g for 30 minutes to obtain nuclei.
The cell fragments accompanying the unbroken cells floated on top of the 
fluid. These floating materials were defined as debris. The purity of 
mitochondrial and microsomal fractions was checked by determination of 
cytochrome oxidase and glucose-6-phosphatase activities, as described by 
De Duve et al. (56) . OMannosidase was used as an enzyme marker for the 
lysosomal fraction (61). The purity of the nuclear fraction was checked 
by microscopic examination. Those fractions with minimum cross contami­
nation of subcellular fractions were used for the subsequent studies.
For"the determination of protein-bound carbohydrates in subcel­
lular fractions, the protein from all the fractions was precipitated 
with 10% trichloroacetic acid; lipids were removed from all of the frac­
tions by washing successively with 95% ethanol, 100% ethanol, chloroform- 
methanol (2:1), benzene, and finally with ethyl ether, as described by 
Busch ^  (62). The lipid-free protein powders were used for subse­
quent chemical analysis.
Microsomal membrane was prepared from the microsomal, fraction 
by extracting with sodium deoxycholate as described by Littlefield (63). 
The microsomal fraction from 10 gms of wet liver was first suspended in 
3 ml of freshly prepared 5% sodium deoxycholate in 0.03 M  tris buffer, 
pH 7.4, with the use of glass homogenizer, then 0.03 M  tris buffer, pH 
7.4, containing 5 mM MgCl2 was quickly added to reach the final volume of 
30 ml. The resulting suspension was immediately centrifuged at 78,000 
X g in a Spinco Model L ultracentrifuge (No. 30 rotor) for two hours. 
After centrifugation, the supernatant was mixed with an equal volume of
14
cold acetone added with constant stirring. The protein solubilized by 
sodium deoxycholate was completely precipitated by 50% acetone. The pre­
cipitate was then washed with 95% ethanol, 100% ethanol, chloroform- 
methanol (2:1), benzene and ether as described by Busch e_t (62).
Hepatectomy of Rats 
The animal was first anesthetized with Nembutal (50 mg/kg body 
wt.) and a long midline incision was made on the ventral surface, start­
ing from the xiphoid cartilage and ending just above the pubis. With a 
light pull on the stomach, the esophagus was visualized and ligated to 
prevent air going into the stomach when artificial respiration was used. 
After elevation of the intestine, the superior mesenteric vessels were 
seen and ligated. Then the portal vein was quickly ligated. Ligation of 
the inferior vena cava was done twice, the first ligation was made below 
the liver and above the renal veins. This could be done easily if the 
peritoneum on both sides was previously snipped by a pair of fine scis­
sors. The other ligation of the inferior vena cava was done between the 
liver and the diaphragm. This was a difficult step to do without punc­
turing the very thin diaphragm. The safest way proved to be to clean the 
fascia along the liver and inferior vena cava first, then to place a 
thread around the inferior vena cava with the help of an aneurism liga­
ture needle and thus ligate the inferior vena cava. After the ligation 
of inferior vena cava, the liver can be removed easily. Closure of the 
abdomen was done by two lines of continuous sutures after irrigating the 
peritoneum with two or three milliliters of normal saline. Two or three 
milliliters of 5% glucose solution was injected intraperitoneally every 
hour.
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Administration of Radioactive Compound to the Rats 
The radioactive compound was dissolved in saline to make a con­
centration of 10 pc per 0.5 ml. The animal was anesthetized with Nembu­
tal. The saphenous vein was exposed by a short skin incision about half 
way down the medial surface of the thigh. One half milliliter of isotope 
material was injected into the saphenous vein by a tuberculin syringe 
fitted with a 27 gauge needle. After the injection, the skin was closed 
with a few sutures. In the case of hepatectomized rats, the isotope was 
injected into the jugular vein.
Measurement of Radioactivity 
Each radioactive sample was prepared by suspending 5 to 10 mg 
of lipid free subcellular fraction in 2 ml of distilled water by means 
of a Potter-Elvehjem type homogenizer. One milliliter aliquots were 
plated on stainless steel planchets and counted in the gas-flow counting 
system (Nuclear Chicago). Proper corrections were made for self-absorp­
tion by means of a curve previously prepared with a known amount of 
radioactive glucosamine added to various amounts of a suspension of lyo- 
philized rat liver. In the case of serum samples 0.05 to 0.5 ml aliquots 
were pipetted directly to the planchet and counted in the gas-flow count­
ing system after being air dried.
Chemicals 
Radioactive Compounds 
D-Glucosamine-l-C-14 (3.1 |ic/|imole) and L-leucine-1-C-14 (14.5 
(ic/pmole) were purchased from New England Nuclear Corp., Boston, Massa­
chusetts. Both radioactive compounds were chromatographically pure as 
shown on the radiochromatograms which were sent along with the radio-
16
active compounds from the company.
Proteolytic Enzyme and Anti Serum 
Pronase-P, Streptomyces griseus protease (64) was purchased from 
the California Corporation for Biochemical Research. Rabbit anti-rat 
serum was purchased from Mann Research Laboratories, Inc.
Analytical Methods 
For the determination of sialic acid in subcellular fractions 
the protein powder was suspended in 0.1 N H2S0^ and dispersed by sonica- 
tion with a Biosonic Ultrasonic Probe (Bronwill-Blackstone). The sus­
pension was then subjected for one hour to hydrolysis ..at 80°C in an oven 
equipped with an automatic shaker; the liberated sialic acid was deter­
mined by the thiobarbituric acid method of Warren (65). It was found 
that hydrolysis of subcellular fractions with 0.1 N H2S0^ at 80°C for 1 
hour resulted in the release of material that produced a chromophore with 
an absorption maximum at 532 mp, by Warren's periodate-thiobarbituric 
acid reagents. This was especially prominent in the case of the nuclear 
fraction. This chromophore could not be removed effectively by chroma­
tography on Dowex 1 or by extraction with isoamyl alcohol. The absorp­
tion at 549 mp due to sialic acid was consequently corrected for absor- 
bency at 532 mp as proposed by Warren (65).
Total hexosamine was determined according to the method of 
Boas (66). Qualitative identification of neutral sugars and amino sugars 
was made by paper chromatography with Whatman No. 1 filter paper and the 
solvent system containing n-butanol-pryidine-0.1 N HCl (5:3:2), and pyri- 
dine-ethylacetate-water (1:24:0.8). Carbohydrates were detected by dip­
ping the chromatogram, into 2-aminobipheny1 reagent (67). For the quanti-
17
tative determination of individual monosaccharides, the developed spots 
were cut from the paper and eluted with methanol for 15 minutes at room 
temperature. The optical density of the colored solutions was measured 
at 400 m|a. Standard sugar samples were always included with each chroma­
tographic separation. Subcellular fractions were prepared for the 
chromatographic identification of neutral sugars by an initial hydrolysis 
of 200 mg of the sample with 5 ml of 1 N HCl in a tightly closed screw- 
capped tube in a water bath at 100°C for 6 hrs. The hydrolysate was 
evaporated to dryness vacuo to remove all HCl. The residue was taken 
up with a minimal amount of water and passed through a Dowex 50 (hydrogen 
form) column (1 X 10 cm). The neutral sugars were eluted with water 
until the solution gave a negative enthrone test. The eluate was evapor­
ated to dryness and analyzed for galactose and mannose according to the 
procedure described previously. Fucose was determined by the cystéine- 
HgSO^ method of Dische and Shettles (68). Quantitative analysis of 
glucosamine and galactosamine was performed by the Spinco amino acid 
analyzer with the short column technique. The glucosamine and galactos­
amine peaks appeared in about 40 minutes before the lysine peak. The 
glucosamine peak preceded the galactosamine peak by 10 minutes. For the 
determination of uronic acid, 100 mg aliquots of different fractions 
were placed in a 20 ml tightly screw-capped tube with 4 gm of Dowex 
50-X8 (hydrogen form) and 10 ml 0.1 N HgSO^ and hydrolyzed in a shaking 
oven at 78°C for 72 hrs by the method of Shetlar and Shetlar (69). The 
hydrolysate was filtered through Whatman No. 1 filter paper. The clear 
supernatant was analyzed for uronic acid by Dische's carbazole reagent
(70). The main advantage of using resin hydrolysis is to remove the 
interfering substances such as amino acids produced during the hydrolysis
18
by resin. This method works satisfactorily for the determination of the 
uronic acid content in cartilage and aorta tissues. Protein-bound neutral 
sugar was determined by the tryptophan-H2S0^ method of Shetlar £t al.
(71).
Amino Acid Analys-is 
The protein samples were hydrolyzed with 6.0 N HCl in sealed, 
thickwall tubes at 110°C for 22 hours. Quantitative determinations of 
individual amino acid were carried out by a Technicon amino acid analyz­
er according to the procedure described by Hamilton (72).
Determination of Total Protein 
Total protein was determined by using Folin's phenol reagent 
as described by Lowry et al. (73). Lab-Trol of DADE Reagents Inc.,
Miami, Florida was used as a standard.
/
Determination of Deoxycholic Acid 
Sodium deoxycholic acid was determined by the method of Kier 
(74). The ultraviolet absorption was measured with a Beckman DB Spectro­
photometer .
Determination of a-Mannosidase Activity 
Q-Mannosidase activity was measured by running the assays in 
the presence of 0.1% (v/v) Triton X-100 (Rohm and Haas Co., Philadelphia). 
The reaction mixture contained 1.5 pmoles of £-nitrophenyl-a-D-manno- 
side, Triton X-100, and enzyme in 1.5 ml of acetate buffer, pH 5.0, 
r/2=0.05. This mixture was incubated at 37°C. At the end of the incu­
bation, 1.5 ml of 0.2 M  Na2C0g were added to the incubation mixture, and
the liberated nitrophenolate ion was determined with a Beckman B Spectro-
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photometer at 420 mp (75). One unit of enzyme is defined as the amount 
of enzyme that will liberate 0.1 pmole of nitrophenol per 30 minutes 
under the conditions stipulated.
CHAPTER IV
EXPERIMENTAL RESULTS
Incorporation of D-Glucosamine-l-C-14 into the Serum 
of Normal and Hepatectomized Rats
As stated in Chapter II, when the specific activities of the 
bound glucosamine in liver and in serum were plotted as the function of 
time after administration of glucose-U-C-14 or glucosamine-l-C-14 into 
the rats, Spiro (23) and Shetlar e_t al. (25) found that liver and serum 
glucosamine meet the criteria for the precursor-product relationship as 
formulated by Zilversmit, Entenman and Fishier (76). Both Spiro and 
Shetlar's results suggested that the liver is the major site of serum 
glycoprotein biosynthesis. In order to obtain the further evidence that 
liver is the actual site for the biosynthesis of serum glycoprotein, 
observations were made of the incorporation of D-glucosamine-l-C-14 into 
serum protein of rats before and after complete hepatectomy. Figure 1 
shows the specific activity of serum protein at various times after intra­
venous injection of D-glucosamine-l-C-14 into the normal and hepatecto­
mized rats. All serum samples were dialyzed against running tap water 
for 48 hours to remove any free radioactive glucosamine. In the normal 
rats, very rapid and efficient incorporation of radioactivity into serum 
proteins was noticed. This radioactivity continued to increase up to 3 
hours after injection. However, no appreciable incorporation of radio­
activity into serum protein could be detected in the hepatectomized rats
20
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Figure 1.— Incorporation of D-glucosamine-l-C-14 into the serum 
of normal (O) and hepatectomized (#) rats. D-glucosamine-l-C-14 (10 pc) 
was administered intraveneously into each rat. Each point represents 
the mean value of three rats.
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within three hours after injection of glucosamine-l-C-14. The results 
of this experiment clearly indicate that the incorporation of radioactive 
glucosamine into serum glycoprotein is largely dependent on the presence 
of the liver.
Fractionation of Rat Liver and Walker 
256 Carcinosarcoma Tissue
Rat liver and Walker 256 carcinosarcoma tissue were fraction­
ated according to the method described in Chapter III. The distribution 
of protein and enzyme activities in subcellular fractions are summarized 
in Table 1. The purity of mitochondrial and microsomal fraction was 
checked by a determination of cytochrome oxidase and glucose-6-phosphatase 
activities. a-Mannosidase was used as an enzyme marker for lysosomal 
fraction. The purity of the nuclear fraction was checked by microscopic 
examination. The protein from all the fractions was precipitated with 
10% trichloroacetic acid; lipids were removed from all of the fractions 
by washing successively with a series of lipid solvents as described by 
Busch et a l . (62).
Mechanism of the Biosynthesis of Serum 
Glycoprotein in Rat Liver
Incorporation of D-Glucosamine-l-C-14 into the 
Subcellular Fractions of Rat Liver
As described in the previous section, the liverless rats failed 
to incorporate detectable amounts of D-glucosamine-l-C-14 into serum 
glycoprotein. It can be concluded that liver is the major site respon­
sible for incorporation of radioactive glucosamine into serum glycopro­
tein. In order to investigate the site of subcellular incorporation,the 
radioactivity associated with subcellular fractions after intravenous
23
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injection of D-glucosamine-l-C-14 was examined. The specific activity 
(counts per minute per mg protein) of various subcellular fractions as 
well as serum protein at time intervals from 5 minutes to four hours are 
summarized in Figure 2. A. rapid incorporation of radioactivity into 
lysosomal and microsomal fractions was noticed. The radioactivities in 
these two fractions continued to increase up to 2 hours after injection 
and gradually decreased thereafter. The specific radioactivity of the 
dialyzed serum increased somewhat slower and reached a maximum at 3 hours. 
Considerable amounts of radioactivity were also found associated with the 
mitochondrial fraction. Very little activity was associated with nuclear 
and soluble fractions. The specific activity of the lysosomal fraction, 
in terms of count per minute per mg protein, was the highest among those 
fractions observed. However, this fraction represents only 3.8% of the 
dried weight of liver (See Table 1). On the other hand, the specific 
activity of the microsomal fraction was very close to that of the lyso­
somal fraction, but this fraction constitutes about 20% of the liver 
(See Talbe 1). On the basis of the total radioactivity, the microsomal 
fraction has much more radioactivity than-any other fraction. Figure 3 
shows the specific radioactivity per p.mole of hexosamine in microsome, 
lysosome and serum. The microsomal fraction has the highest specific 
radioactivity. From both the specific radioactivity and the total radio­
activity, it appears that the microsomal fraction is most active in the 
incorporation of D-glucosamine-l-C-14 into serum glycoprotein.
Incorporation of L-Leucine-l-C-14 into 
Subcellular Fractions of Rat Liver
In order to compare the mechanism of the incorporation of D- 
glucosamine-l-C-14 into subcellular fractions of rat liver with that of
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Figure 2 . Incorporation of D-glucosamine-l-C-14 into the sub­
cellular fractions of rat liver after injection with 10 |ic of D-glucos­
amine-l-C-14. Each point represents the mean value of three rats.
— , dialyzed serum;  ■ -----■ ---- , nucleus;
O — o  — — , microsome;  # -----# ---- , lysosome;
  A A , supernatant;  A ---- A ---- , mitochondria.
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Figure 3.— -Incorporation of D-glucosamine-l-C-14 into the sub­
cellular fractions of rat liver after injection with 10 [4c of D-glucos­
amine-l-C-14. The specific radioactivity expressed as counts per minute 
per pmole hexosamine in microsome, lysosome and dialyzed serum. Each 
point represents the mean value of three rats.
 # ----# ---- , microsome;  O ---- O ---- , lysosome;
— — A   A --- , dialyzed serum.
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an amino acid; L-leucine-l-C-14 was administered to the rats as previous^, 
ly done with D-glucosamine-l-C-14. The radioactivity associated with sub­
cellular fractions was followed at various time intervals after the injec­
tion. Figure 4 shows the general pattern of L-leucine-l-C-14 incorpora­
tion. Among.the fractions examined, the microsomal fraction had the high­
est radioactivity. Considerable amounts of radioactivity were also as­
sociated with lysosomal, and mitochondrial fractions. Very little radio­
activity was associated with nuclear and soluble fractions. The specific 
radioactivity of the microsomal fraction reached a maximum at 10 minutes 
after the injection. The over all pattern was compatible with the well 
established fact that the microsomal fraction is the site of cytoplasmic 
protein synthesis (77, 78). When Figures 2 and 4 are compared, the pat­
tern of incorporation of D-glucosamine-l-C-14 is obviously different from 
that of L-leucine-l-C-14. The rate, in terms of time, of incorporation 
of L-leucine-l-C-14 into the microsomal fraction is much faster than the 
incorporation of D-glucosamine-l-C-14. The incorporation of L-leucine- 
l-C-14 reached a plateau at 10 to 30 minutes, while the incorporation of 
D-glucosamine-l-C-14 took 1 to 2 hours to reach the maximum activity.
Incorporation of D-Glucosamine-l-C-14 and L-Leucine-l-C-14 
into the Sodium Deoxycholate Soluble and Insoluble 
Fractions of Rat Liver Microsome
As indicated previously D-glucosamine-l-C-14 was incorporated 
into the microsomal fraction of rat liver, but the average rate of incor­
poration of D-glucosamine-l-C-14 was much slower than that of L-leucine- 
l-C-14. An attempt was therefore made to study the incorporation of D- 
glucosamine-l-C-14 and L-leucine-l-C-14 into the sodium deoxycholate 
soluble and insoluble fractions of the microsomes. For direct comparison.
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Figure 4.— Incorporation of L-leucine-l-C-14 into the subcel­
lular fractions of rat liver after injection with 2.43 (ic of L-leucine- 
l-C-14. Each point represents the mean value of three rats.
“ “— O — —  O — — > lysosome;  # -----# ----, microsome;
— —  A A  , supernatant;  A -----A ----> mitochondria.
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the individual rat received 10 pc of either D-glucosamine-l-C-14 or L- 
leucine-l-C-14 intravenously and the rats were sacrificed at various time 
intervals. After separation of the microsomal fraction by differential 
centrifugation, microsomes were further treated with freshly prepared 
0.5% sodium deoxycholate to obtain deoxycholate soluble (membrane and its 
contents), and insoluble (ribosomes) fractions. The radioactivity in 
these fractions was determined and is presented in Figures 5 and 6 .
Figure 5 shows the incorporation pattern in which L-leucine-l-C-14 was 
administered to the rats. Very quick labelling and disappearance of the 
radioactivity in the deoxycholate insoluble fraction was noticed. In 
the deoxycholate soluble fraction, radioactivity increased progressively, 
reached a plateau at 10 minutes after injection, and then increased 
slowly up to 30 minutes. The results were very similar to those reported 
by Littlefield, Keller and Zamecnik (63) who employed radioactive leucine 
and valine to demonstrate that the cytoplasmic ribonucleoprotein parti­
cles were the site of initial incorporation of amino acids into proteins.
As presented in Figure 6 , the incorporation pattern of D-glucos- 
amine-l-C-14 into deoxycholate soluble and insoluble fractions of rat 
liver microsome was very different from that of L-leucine-l-C-14. In 
contrast to L-leucine-l-C-14 incorporation, very little D-glucosamine- 
l-C-14 was incorporated into the deoxycholate insoluble fraction during 
the experimental period (5 minutes to 3 hours). In the deoxycholate 
soluble fraction, the incorporation of D-glucosamine-l-C-14 reached a 
peak approximately 2 hours after the administration of radioactive 
tracer. In comparison, the rate of incorporation of D-glucosamine-l-C-14 
into the deoxycholate soluble fraction was slower than that of L-leucine- 
l-C-14. Table 2 summarizes the distribution of dried weight and radio-
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Figure 5.— Incorporation of L-leucine-l-C-14 into the deoxy­
cholate soluble and insoluble fractions of rat liver microsome after 
injection with 10 |ic of L-leucine-l-C-14. Each point represents the 
mean value of three rats.
 O  O  , deoxycholate soluble fraction;
— —  — • — -  , microsome;
 — 4 ----, deoxycholate insoluble fraction.
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Figure 6 .-“ Incorporation of D-glucosamine-l-C-14 into the deoxy­
cholate soluble and insoluble fractions of rat liver microsome after 
injection with 10 pc of glucosamine-l-C-14. Each point represents the 
mean value of three rats.
— —  #  — —— • ,  deoxycholate soluble fraction;
— O  — — , microsome;
 A " " A — — , deoxycholate insoluble fraction.
32
TABLE 2
DISTRIBUTION OF DRY WEIGHT AND RADIOACTIVITY IN DEOXYCHOLATE 
SOLUBLE AND INSOLUBLE FRACTIONS OF RAT LIVER MICROSOME 
1.5 HOURS AFTER INJECTION OF D-GLUCOSAMINE-l-C-14
Fractions
Dry Weight^ Radioactivity
Expt. 1
7o
Expt. 2
%
Exp t . 1
%
Expt. 2 
%
Whole Homogenate 100 100 100 100
Microsomes 6.1 7.8 19.5 17.2
Deoxycholate 
Soluble Fraction
3.8 5.6 15.6 16.2
Deoxycholate 
Insoluble Fraction
2.0 2.2 1.1 1.0
The weight after treatment of the fractions with lipid sol­
vents as described in the test.
One rat was used in each experiment.
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activity in the deoxycholate soluble and insoluble fractions of rat liver 
microsomes. Ninety minutes after injection of D-glucosamine-l-C-14, more 
than 80% of the total radioactivity associated with the microsomal frac­
tion was found to be located on the deoxycholate soluble fraction. About 
6% of the total radioactivity in the microsomes was found in the deoxy­
cholate insoluble fraction.
In accordance with these results, it may be suggested that 
during the course of biosynthesis of glycoprotein, the protein moiety is 
first synthesized in ribosome and then released to the membranous por­
tion of the microsome where D-glucosamine-l-C-14 is attached to the pro­
tein moeity.
Incorporation of D-Glucosamine-l-C-14 
into Walker 256 Carcinosarcoma
A consistent increase of serum glycoproteins in patients with 
cancer has been described by numerous investigators (5, 25, 79, 80). 
Elevation of the protein-bound hexose level in rats bearing Walker 256 
tumor was first reported in 1950 by Shetlar and his associates (81).
The significance of the elevated serum glycoproteins in tumor bearing 
animals is still unknown. The possibility that tumor cells may liberate 
protein-bound carbohydrate into the circulation has been proposed (8 ,
82, 83).
If Walker 256 tumor does really liberate protein bound carbo­
hydrate into the blood, one should be able to detect the biosynthesis 
of glycoprotein in the tumor tissue.
The present study was designed to investigate the biosynthesis 
of glycoprotein by studies of the incorporation of D-glucosamine-l-C-14 
into tumor tissue after intravenous injection of this compound to the
34
rat bearing Walker 255 tumor. As shown In Figure 7, D-glucosamine-l-C-14 
was readily incorporated into subcellular fractions of Walker tumor. 
Generally the subcellular fractions of Walker tumor take up the radio­
activity slower than those of the liver (See Figure 2). Microsomal and 
mitochondrial fractions were most active in incorporating radioactive 
glucosamine. The nuclear fraction has relatively low radioactivity. In 
contrast to the incorporation pattern in the liver subcellular fractions, 
the soluble fraction of Walker tumor had rather high radioactivity. How­
ever, this may be due to the contamination by plasma proteins, since the
solid tumor is difficult to perfuse.
In order to compare the rate of incorporation of amino sugar and 
amino acid into the subcellular fractions of Walker tumor, L-leucine-l-C- 
14 was also used to study the time course of the labelling of various 
subcellular fractions in tumor tissue. As presented in Figure 8 , the 
incorporation of L-leucine-l-C-14 into subcellular fractions of Walker 
256 tumor is much faster than that of D-glucosamine-l-C-14. The micro­
somal fraction was rather quickly labeled and reached the plateau at 30
minutes after the injection. The radioactivity in cytoplasmic sap
(soluble fraction) continued to increase after the microsomal fraction 
reached its maximum activity.
The results of the above experiment suggest that a tumor is 
able to perform independent synthesis of glycoprotein. The synthetic 
pattern, however, was not similar to that of protein biosynthesis, as 
indicated by leucine incorporation. For more evidence that Walker tumor 
is able to synthesize glycoprotein independently, D-glucosamine-l-C-14 
was injected into the hepatectomized rats bearing Walker 256 tumors.
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Figure 7. —  Incorporation of D-glucosamine-l-C-14 into the sub­
cellular fractions of Walker 256 tumor after injection with 10 pc of D- 
glucosamine-l-C-14. Each point represents the mean value of three rats. 
— — O ------- O  , supernatant;  # ---- # -----, microsome;
mitochondria; nucleus.
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Figure 8 .— Incorporation of L-leucine-l-C-14 into the subcel­
lular fractions of Walker 256 carcinosarcoma after injection with 10 pc 
of L-leucine-l-C-14. Each point represents the mean value of three 
rats.
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 A ----A ----- } mitochondria.
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As shown in Table 3, Walker 256 tumor tissue was still able to incor­
porate D-glucosamine-l-C-14 into its subcellular fraction after complete 
hepatectomy. The sera from the same rats were subjected to paper electro­
phoresis using a Spinco Model R electrophoretic system. Thirty micro­
liters of whole serum were applied on the paper strips. After electro­
phoresis, ;the paper strips were examined for the radioactivity by using 
a Baird-Atomic 4ff strip scanner. Each fraction on the paper strips was 
also separated by cutting and examined for radioactivity with a Nuclear 
Chicago liquid scintillation counter (720' series). No detectable radio­
activity was found in any of the serum protein fractions. Similar 
results were obtained with a low background counter. These results may 
be due to the short duration of the experiment or the poor circulation 
in the hepatectomized animal. It was very difficult to keep hepatecto­
mized rats alive more than 3 hours. When tumor slices were incubated in 
vitro, with the serum from the same animal, in the presence of D-glucos- 
amine-l-C-14, a definite up take of radioactivity was also observed (See 
Table 3). When the microsomal fraction of Walker tumor, which was label­
ed with glucosamine-l-C-14, was further separated into deoxycholate solu­
ble and insoluble fractions (Table 4), most of the radioactivity was as­
sociated with the deoxycholate soluble fraction. Very little radio­
activity was presented in the deoxycholate insoluble fraction.
Nature of the Radioactive Compound in 
the Microsomal Fraction
The previous studies on the incorporation of D-glucosamine-
l-C-14 into various tissue were mainly based on the measurement of the 
radioactivity present in the tissues. It is therefore important to 
establish the nature of the radioactive compound in that tissue. Since
38
TABLE 3
INCORPORATION OF GLUCOSAMINE-1-G-14 INTO WALKER TUMOR TISSUE 
OF HEPATECTOMIZED RATS, INTO TUMOR TISSUE IN VITRO 
AND INTO LIVER TISSUE IN VITRO
Fractions
Walker Tumor 
cpm per mg Protein
Liver 
cpm per mg 
Protein
Hepatectomized 
90 min.
Slice* 
180 min.
Slice^ 
180 min.
Mitochondria 58 112 60
Lysosome 57 139 59
Microsome 47 120 107
Nucleus 44 177 51
Supernatant 39 136 24
Twenty grams of tissue slices were incubated with 5 //c of 
glucosamine-l-C-14 in the presence of 10 ml of rat serum.
39
TABLE 4
DISTRIBUTION OF RADIOACTIVITY IN DEOXYCHOLATE SOLUBLE AND 
INSOLUBLE FRACTIONS OF WALKER TUMOR MICROSOME 1.5 
HOURS AFTER INJECTION OF D-GLUCOSAMINE-1-C-14
Fractions Dry Weight 
%
Radioactivity
%
Whole Homogenate 100 100
Microsomes 10.9 21.9
Deoxycholate 
Soluble Fraction
4.5 14.2
Deoxycholate 
Insoluble Fraction
6.4 7.7
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the liver microsomes were the subcellular particles most actively incor­
porating D-glucosamine-l-C-14 into glycoprotein, the nature of the radio­
activity associated with neutral sugars, amino sugars and amino acids
in this fraction was carefully examined.
For the identification of sialic acid, 10 mg of the microsomes
were treated with 0.1 N H 2SO4 at 80° for 1 hour. This was reported to 
cleave the majority of sialic acid from glycoproteins (84). Quantitative 
measurement of sialic acid was made by Warren's thiobarbituric acid 
method (65). The chromophore developed in this reaction was extracted 
with cyclohexanone. The intensity of ruby red color was measured by 
colorimetric determination. An aliquot of the cyclohexanone extract 
was plated out on a stainless steel planchet for determination of radio­
activity (31). An authentic sialic acid sample was also carried through 
all the procedures. The absorption spectra of the chromophores obtained 
from microsome and authentic sialic acid are presented in Figure 9. Very 
good correspondence of these two absorption spectra was observed. It is 
known that all of the free 2-keto-3-deoxy sugars will give the same 
chromophore using Warren's thiobarbituric acid procedure. To be certain 
that the chromophore obtained from the microsomal fraction was really 
derived from sialic acid, a sample of microsomal hydrolysate was passed 
through anion exchange resin (AG 2 x 8 )  and sialic acid was isolated from 
the column by the procedure described by Svennerholm (84). The isolated 
sialic acid was then determined by Warren's thiobarbituric acid procedure. 
The amounts and specific radioactivities of the microsomal sialic acid 
preparations, whether determined after O.IN hydrolysis or after
isolation by Svennerholm's method, were essentially the same. This proves 
that the chromophore obtained by Warren's method from microsomal hydroly-
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Figure 9.— The absorption spectra of the chromopores obtained 
from sialic acids by Warren's thiobarbituric acid method. (A.) authentic 
sialic acid (B) sialic acid from the rat liver microsomes. The spectra 
was determined by Cary Model 14 recording spectrophotometer.
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sate was from sialic acid, therefore the direct application of Warren's 
method to microsomal preparation was sufficient to estimate the sialic 
acid content. Table 5 summarizes the amount of protein bound radioactiv­
ity contributed by sialic acid and by hexosamine in mitochondrial, micro­
somal and supernatant fractions.
The radioactivities associated with sialic acid in mitochondrial, 
microsomal and supernatant fractions were 5.5%, 8.4% and 13.0% respective­
ly. Since the specific radioactivities of sialic acid and the total 
radioactivities in these three fractions were very close, the higher per­
centage of radioactivity associated with sialic acid in supernatant frac­
tion indicated that the soluble fraction had a higher content of sialic 
acid relative to hexosamine; also part of this was due to the lower spec 
cific radioactivity of hexosamine in supernatant fraction.
For the determination of radioactivity associated with neutral
sugars, amino acids and hexosamine, 50 mg of dried protein powder were
suspended in 2 ml of 4 N HCl in a tightly closed screw cap tube and hydro­
lyzed in a boiling-water bath for 6 hours. The resulting hydrolysate
was taken to dryness in a vacuum oven to remove HCl. The residue was 
then suspended in distilled water and passed through a 0.9 x 15 cm Dowex- 
50 column according to a method described by Boas (6 6 ). Neutral sugars 
were washed from the column until the eluent showed a negative enthrone 
test. The hexosamine was eluted from the column with 2 N HCl. The first 
10 ml of the eluent were collected as hexosamine fraction and the follow­
ing 20 ml of the eluent were collected as amino acid fraction. After 
drying these fractions, an aliquot of each fraction was taken to measure 
the radioactivity using a Nuclear Chicago gas flow counter. No radio­
activity was detectable in either the neutral sugar or the amino acid
4.3
TABLE 5
PROTEIN-BOUND RADIOACTIVITY ASSOCIATED WITH SIALIC ACID AND 
HEXOSAMINE IN MITOCHONDRIAL, MICROSOMAL AND SUPERNATANT 
FRACTIONS OF RAT LIVER TISSUE TWO HOURS AFTER 
ADMINISTRATION OF ISOTOPE
- Mitochondria Microsome Supernatant
^cpm per |imole sialic acid 9,460 12,144 11,441
pmole sialic acid per g protein 8.4 11.1 1.3
cpm associated with sialic acid 
per g protein
79,464 134,794 14,873
cpm per ^mole hexosamine 40,418 45,972 15,269
yUmole hexosamine per g protein 32.9 37.5 5.9
cpm associated with hexosamine 
per g protein
1,329,752 1,723,950 90,087
Sum of cpm from sialic acid and 
hexosamine per g protein
1,409,216 1,858,744 104,960
cpm per g protein measured 1,446,000 1,600,000 114,000
% cpm associated with sialic acid 5.5 8.4 13.0
% cpm associated with hexosamine 92.0 107.7 79.0
% Total Radioactivity associated 
with sialic acid and hexosamine
97.5 116.1 92.0
cpm; Counts per minute
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fractions. The hexosamine fraction was highly radioactive. Hexosamine 
was also determined quantitatively by Boas' method (6 6) and specific 
radioactivity of hexosamine was thus obtained. All three fractions were 
also examined for radioactive spots by paper chromatography and autoradio­
graphic technique. For neutral sugars and hexosamine, the chromatogram 
was developed in a solvent system consisting n-butanol: pyridine : 0.1 H HCl 
(5:3:2). For amino acids, the chromatogram was developed in the top layer 
of n-butanol:acetic acid: water (4:1:5).
The autoradiograms of each chromatograph were made by direct contact 
for 3 weeks of the paper with blue brand medical X-ray film from Eastman 
Kodak Company. In the neutral sugar and amino acid fractions, no radio­
active spot was found, but in the hexosamine fraction, a major and a 
minor spot was identified as glucosamine and galactosamine, respectively. 
Also a trace of radioactivity showed as a tailing strip. This result 
suggests that most of the radioactivity remained as hexosamine after ad­
ministration of D-glucosamine-l-C-14. No significant amount of radioc 
activity was converted into neutral sugars and amino acids under this 
experimental condition. The fact was also supported by the analytical 
data shown in Table 5. The radioactivity associated with hexosamine in 
mitochondrial, microsomal and supernatant fractions were 92%, 107.7%, 
and 79%, respectively. The total radioactivity obtained from sialic acid 
and hexosamine in each fraction were calculated by the following formula:
% Total radioactivity
associated with sialic = 100 x
acid and hexosamine
cpm/pmole ^ pmole sialic 
sialic acid acid/g protein 
cpm/g protein measured
cpm/ pmole ■ pmole hexosamine/g
+ hexosamine________protein_________
cpm/g protein measured
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The values obtained were 116.1% in microsomes, 97.5% in mitochondria and 
92% in supernatant fraction. These data strongly suggested that no ap­
preciable alteration of D-glucosamine-l-C'-14 occurred under these experi­
mental conditions. Only a small percentage of the radioactivity was 
converted into sialic acid. No detectable amount of radioactivity was 
converted into protein-bound neutral sugars and amino acids. Therefore, 
D-glucosamine-l-C-14 is an excellent tracer for the studies on glycoprotein 
biosynthesis.
The Linkage of D-Glucosamine in Deoxycholate 
Soluble Fraction of Rat Liver Microsome
In recent years, more and more evidence has been accumulated that 
aspartic acid and D-glucosamine are responsible for linking the polypep­
tide and oligosaccharide chains of several glycoproteins isolated from 
serum and other sources (85).
Our experimental results presented above suggested that deoxy­
cholate soluble proteins of the microsomal fraction are involved in the 
biosynthesis of glycoprotein. If serum glycoproteins are synthesized in 
the deoxycholate soluble fraction of microsome and then by some unknown 
mechanism liberated to the serum, one should be able to find a linkage 
of D-glucosamine to the protein moiety similar to that found in serum 
glycoprotein (85). The following study was undertaken to investigate the 
linkage between the carbohydrate and peptide moieties of the deoxycholate 
soluble protein isolated from the rat liver microsomes.
Two grams of the deoxycholate soluble fraction were suspended in 
20 ml of 0.01 M  CaCl2 and adjusted to pH 7.8 with 1 N NaOH. Three milli­
grams of Pronase was added. The reaction mixture was then left at 37° for
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48 hours. The progress of the reaction was followed by the decrease of 
pH in the reaction mixture. During those 48 hours, the pH of the reac­
tion mixture was examined from time to time, and adjusted to pH 7.8 by 
adding a few drops of 1 N NaOH. At subsequent 8 to 9 hour intervals, 
additional 3 mg quantities of Pronase were added to this mixture. After 
the digestion, an insoluble precipitate was removed by centrifugation, 
and the clear supernatant was brought to 80% ethanol concentration.
After being allowed to stand overnight in the cold, the solution was 
centrifuged, and the precipitate was dissolved in 5 ml of water. This 
solution was brought to 3% trichloroacetic acid concentration and cen­
trifuged to remove the insoluble precipitate, and the clear brownish 
supernatant was applied to a column (3 x 40 cm) of Sephadex G-25 equili­
brated with distilled water. Three milliliter fractions were collected 
at the flow rate of 0.44 ml per minute. The fractions were examined for 
radioactivity and for the substances positive in the ninhydrin reaction. 
Figure 10 shows the pattern of Sephadex G-25 gel filtration. The radio­
activity was eluted at the void volume of the column and the ninhydrin 
positive substances come after the radioactive peak.
A. small amount of radioactivity was also found in the 80% 
ethanol solution of the Pronase digest. The ethanol solution was concen­
trated to about 10 ml with a vacuum evaporator. The radioactive compound 
in this solution could be separated from the ninhydrin positive substances 
by Sephadex G-25 gel filtration in the same manner as the trichloroacetic 
acid soluble fraction. Essentially, the pattern of gel filtration was 
similar to Figure 10, except the radioactive peak was smaller and the 
ninhydrin positive peak was larger.
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Figure 10.— Gel filtration of Pronase digest of deoxycholate 
soluble fraction from rat liver microsome on Sephadex G-25.
—  ----, ninhydrin r e a c t i o n ;  , radioactivity. Vo, the void volume
of the column.
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The radioactive peaks from gel filtrations were pooled and dried 
by freezing. The glycopeptide fraction thus obtained was dissolved in 2 
ml of 0.01 M  CaCl2 and again subjected to enzymic digestion with 1 mg of 
Pronase for 24 hours. After the second digestion, the solution was treated 
by the same procedure described above. More amino acids were removed from 
the glycopeptide during the second digestion. The radioactive glycopeptide 
obtained from the second digestion was designated glycopeptide I. The dis­
tribution and the recovery of radioactivity are summarized in Table 6 , 
where it is shown that 78.3% of the radioactivity from microsomal membrane 
was recovered in glycopeptide I. Only 6 .6% of the radioactivity was left 
as undigested residue.
Chemical analysis of glycopeptide 1 showed that it was comprised 
of 12.83% sialic acid, 38.1% hexoses, 8 .66% glucosamine and 40.24% amino 
acids. The high content of amino acids in glycopeptide 1 may be due to 
the fact that the considerable amount of sialic acid presenting in glyco­
peptide 1 interferes with the enzymic digestion by Pronase. To eliminate 
the interference by sialic acid, glycopeptide 1 was further subjected to 
mild acid hydrolysis by means of 0.1 N HCl at 80° for one hour. This 
procedure hydrolyzes the bound sialic acid from glycoprotein (84). After 
hydrolysis, the glycopeptide was separated from sialic acid by a Sephadex 
G-25 column chromatography. The glycopeptide fraction was pooled and 
freeze-dried. The dried material, free from sialic acid, was subjected 
to a third Pronase digestion as described before. The glycopeptide ob­
tained from final digestion was designated as glycopeptide II. Figure 11 
shows the scheme of Pronase digestion and Table 7 summarizes the chemical 
analysis of deoxycholate soluble material from rat liver microsome, glyco­
peptide I and glycopeptide II.
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TABLE 6
DISTRIBUTION AND RECOVERY OF DRY WEIGHT 
AND RADIOACTIVITY IN THE PRONASE DIGEST 
OF DEOXYCHOLATE SOLUBLE FRACTION OF 
RAT LIVER MICROSOME
Fractions
Specific 
Radioactivity 
cpm /mg dried 
Substance
Dry Weight Total
Radioactivity
g % cpm® %
DOC^ Soluble 
Fraction
560 2.000 100.0 1.12 X loG 100.0
Glycopeptide I 31280 0.028 1.4 8.77 X 105 78.3
Undigested
Residue
187 0.363 18.1 6.79 X 104 6.6
Alcohol Soluble 
■ Fraction
116 1.500 75.0 1.75 X 10^ 15.0
cpm; Count per minute
'DOC; Deoxycholate
50
I Deoxycholate Soluble Fraction
,0.01 M  C a d 2 > Pronase 
Centrifugation
i '
i '
Undigested
Residue
— 1
Solution
Adjust to 80% Ethanol
Precipitate
dissolve in H 2O 
Adjust to 3% 
TCA, Centrifuge
Centrifuge
Solution
Solution
Concentrate 
^Sephadex G-25
i
Precipitate
Radioactive Peak
Sephadex G-25 
Radioactive Peak
Second Digestion 
as the procedure 
described above
— ^  Radioactive Peak 
After Second Digestion
Glycopeptide I |
^ 0 . 1  N HCl 80°, 1 hr.
^Sephadex G-25
Glycopeptide Sialic Acid
^^0.01 M  CaClg Pronase
Sephadex G-25
—  .   T  _____ __
Glycopeptide II |
Figure 11. — The scheme of Pronase digestion and separation of 
glycopeptide from deoxycholate soluble fraction of rat liver microsome.
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TABLE 7
CHEMICAL ANALYSIS OF DEOXYCHOLATE SOLUBLE MATERIAL 
FROM RAT LIVER MICROSOME AND ITS GLYCOPEPTIDE 
FROM PRONASE DIGEST
Deoxycholate
Soluble.;
Fraction
Glycopeptide I Glycopeptide II
p m o l ^ b
/ g 7o
[.imol^b
/ g %
p m o l ^ b
/ g 7o
Sialic Acid 8.4 0.26 415 12.8 -
Hexoses 101 1.8 2,117 38.1 3,368 60.6
Glucosamine^ 5.6 0.1 483 8.7 829 14.9
Total Amino Acid 6,555 90 2,768 40.2 1,743 21.3
Radioactivity (cpm/mg)^ 560 31,280 44,903
Weight (g) 2,000 0.028 0.0165
Yield (%) 100 1.4 0.8
Recovery of total 
Radioactivity (%)
100 78.3 65.9
Hexoses 4.3 4.1
Glucosamine 1 1
^As determined by the amino acid analyzer.
^The values are all based on gram or milligram of dry weight.
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Glycopeptide II (Table 7) is a carbohydrate enriched fraction.
It is comprised of 75.5% sugars, of which 60.6% are hexoses and 14.9% is 
glucosamine. The molar ratio of hexoses to glucosamine is the same in 
both glycopeptide I and glycopeptide II. This constant ratio suggests 
that no appreciable amount of hexose was lost in the process of Pronase 
digestion. The yield of glycopeptide II as indicated by dry weight was 
only 0 .8% of the original deoxycholate soluble substance, however, the 
recovery of the total radioactivity in glycopeptide II was 65.9% of the 
original material. This strongly indicates that most of the glucosamihe, 
if not all, is linked to the carbohydrate portion or the core portion of 
the glycopeptide rather than being randomly distributed throughout the 
glycoprotein molecule. Aspartic acid is the most abundant amino acid 
in glycopeptide II (Table 8). Aspartic acid content was almost four 
times greater than any other amino acids. There were about equal amounts 
of threonine, serine, glutamic acid, proline and glycine in glycopeptideII 
while alanine and valine were present in minor amounts. From the analysis 
of amino acid content of glycopeptide I and II, it is clear that generally 
the relative content of amino acids was decreased in these glycopeptides 
except for aspartic acid which was slightly increased. There are about 
equimolar amounts of glucosamine and aspartic acid in glycopeptide II 
(Tables 8 and 9). These results suggest that the carbohydrate moiety is 
very likely linked to the peptide by a glucosamine-aspartic acid linkage. 
The absence of, or low content of some amino acids such as histidine, 
arginine, isoleucine, leucine, alanine, valine, phenylalanine, tyrosine, 
methionine in glycopeptide I and II suggests that these amino acids are 
more readily removed by Pronase digestion. Threonine, serine, glutamic 
acid, proline, glycine residues were more resistant to the digestion by
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TABLE 8
AMINO ACID ANALYSIS OF DEOXYCHOLATE SOLUBLE 
MATERIAL FROM RAT LIVER MICROSOME AND 
ITS GLYCOPEPTIDE AFTER PRONASE DIGEST
Amino Acids
Deoxycholate
Soluble
Fraction
Glycopeptide I Glycopeptide II
pmole/
%
umole^
%
pmole/
%
Asp. 649 8.64 693 11.69 719 9.6
Thr. 342 4.07 235 3.42 187 2.2
Ser. 408 4.29 217 2.82 185 2.0
Glu. 728 12.02 435 8.78 181 2.9
Pro. 317 3.65 258 3.62 182 2.1
Gly. 492 3.70 280 2.59 179 1.3
Ala. 497 4.43 110 1.20 68 0.5
Val. 448 5.25 65 1.03 42 0.4
Cyst. - - - - - - - - - - - -
Meth. 126 1.88 - - - - - - - -
lieu. 314 4.12 31 0.48 - - - -
Leu. 667 8.75 193 0.80 - - - -
Tyr. 180 3.26 - - “ - - - - -
Phe 316 5.22 - - - - " - - -
Lys. 618 9.10 143 2.59 - - - "
His. 185 2.89 45 0.83 " - - -
Arg. 268 4.70 63 1.31 - - - -
^The values are all based on gram of dry weight
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Pronase. The resistance of these amino acid residues to Pronase digestion 
may be due to the presence of proline as it has been reported that L-gly- 
cyl-L-proline is not hydrolyzed by Pronase and that L-glycyl-L-prolyl-L- 
leucine is poorly hydrolyzed at the linkage between proline and leucine ( 64)
Carbohydrate Content in Subcellular 
Fractions of Rat Liver and of 
Walker 256 Carcinosarcoma
Studies of the incorporation of D-glucosamine-l-C-14 into sub- 
cellular fractions of rat liver and Walker 256 carcinosarcoma suggest that 
D-glucosamine-l-C-14 is distributed throughout all of the subcellular 
components. The results also indicate that the microsomal fraction is 
most active in the glycoprotein biosynthesis. Subcellular fractions, 
therefore, ought to contain bound carbohydrate. Although many studies 
of the distribution of enzymes in subcellular fractions exist, the carbo­
hydrate content in these fractions is relatively unexplored. A study of
the carbohydrate content of the subcellular fractions of liver tissue 
and Walker 256 tumor tissue should consequently add valuable information
to the studies of glycoprotein biosynthesis. Yamashina et al. (59) have 
reported that in the rabbit liver the microsomal fraction is richest in 
hexosamine and sialic acid among the fractions. Wallach and Eyler (57), 
Patterson and Touster (58) have reported preliminary observations on the 
distribution of sialic acid in the subcellular fractions of rat liver and 
Ehrlich ascites carcinoma cells. No detailed examination of amino sugars 
and neutral sugars in subcellular fractions of either liver or other 
tissue could be found in the literature. It is the purpose of this sec­
tion to report studies of the distribution of neutral sugars, amino sugars 
and sialic acid in the subcellular fractions of Walker 256 tumor tissue 
and in those of the liver of the same animals.
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Sialic Acid Content in Subcellular Fractions
Table 9 shows the sialic acid content in subcellular fractions 
of rat liver and of Walker 256 carcinosarcoma. The figures for the whole 
homogenate are of the same order of magnitude as those reported by 
Macbeth and Bekesi (56) for acetone extracted tissue. They reported that 
the value for sialic acid as N-acetylneuraminic acid in liver was 78 
mg/100 g acetone dried tissue; in the Walker 256 tumor, it was 240 mg/100 
g tissue protein. Our result calculated on the same basis as theirs 
showed that sialic acid content in liver was 198 mg/100 g defatted dried 
tissue; the Walker tumor, it was 302 mg/100 g defatted dried tissue. It 
is noted that out liver sialic acid is higher than theirs. This may be 
due to the difference in methods of preparing the samples before analysis. 
In general, sialic acid is higher in the subcellular fractions of the 
Walker tumor. In both liver and the Walker tumor, the lysosomal fraction 
contains the highest concentration, based on protein, of sialic acid. 
Mitochondrial and microsomal fractions are next highest in this sugar.
In liver, the sialic acid content of the soluble fractions is relatively 
low. In the Walker tumor, the nuclear fraction is also low in sialic 
acid, but the soluble fraction contains relatively large amounts of this 
sugar.
The presence of sialic acid in the subcellular particles was 
further established by using pneumococcal neuraminidase (87,88). More 
than 90% of the sialic acid in the subcellular particles was released 
by this enzyme. The released sialic acid was isolated by the column 
chromatographic technic of Svennerholm (84), and exhibited the mobility 
in paper chromatography of N-acetylneuraminic acid.
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TABLE 9
DISTRIBUTION OF SIALIC ACID IN SUBCELLULAR 
FRACTIONS OF RAT LIVER AND WALKER 
256 CARCINOSARCOMA. TISSUE
Fractions
No. of
Sialic Acid 
pmole per g Protein
Sialic Acid 
Hexosamine
Animals
Liver Tumor Liver Tumor
Whole Homogenate 15 6.5 ±  0.4* 9.9 +  0.3 1:3.7 1:3.4
Nucleus 12 0.5 + 0.0 5.6 + 0.4 1:22.4 1:4.1
Mitochondria 15 8.4 + 0.5 15.2 +  0.5 1:3.9 1:3.2
Microsome 15 7.5 + 0.0 12.5 +  0.6 1:3.4 1:3.0
Lysosome 15 11.1 +  0.4 18.8 +  0.5 1:3.8 1:2.8
Soluble 13 1.3 + 0.2 11.8 +  0.6 1:4.5 1:2.7
^Values following + signs are standard error of mean.
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Hexosamine Content in Subcellular Fractions 
The hexosamine content of the subcellular fractions of rat liver 
and of Walker 256 carcinosarcoma are summarized in Table 10. Macbeth and 
Bekesi (86) reported their figures of hexosamine content in acetone ex­
tracted tissue. Liver contained 525 mg/100 g acetone dried tissue;
Walker 256 tumor contained 701 mg/100 g tissue protein. Our data on the 
whole homogenate showed that hexosamine content of liver was 422 mg/100 g 
defatted dried tissue; in Walker 256 tumor it was 542 rag/100 g defatted 
dried tissue. Our results agree well with theirs. In both Walker 256 
tumor and liver, hexosamine is about 3 to 4 times higher than sialic acid 
on a molar basis. The ratio of hexosamine to sialic acid is higher in 
liver fractions than in those of Walker 256 carcinosarcoma (Table 9).
Among the subcellular fractions of both tissues, the lysosomal fraction 
contains the greatest amount of hexosamine. Qualitative identification 
of the hexosamine fraction of 3 N HCl hydrolysates^by paper chromatography 
with N-butanol-pyridine-0,1 N HCl (5:3:2) as the solvent system^revealed 
that glucosamine is the major amino sugar in all of the fractions.
However, a small amount of galactosamine was also detected. Quantitative 
analysis of glucosamine and galactosamine was carried out with a Spinco 
amino acid analyzer; the molar ratio of galactosamine to glucosamine is 
smaller in the subcellular fractions of the liver, except nuclear fraction, 
than in those of the Walker tumor.
Neutral Sugar Conteht of Subcellular Fractions 
Galactose, mannose, and fucose are the major neutral sugars 
identified in most glycoproteins. The presence of these sugars was 
qualitatively demonstrated by the paper chromatography in the solvent
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TABLE 10
DISTRIBUTION OF HEXOSAMINE IN SUBCELLULAR 
FRACTIONS OF RAT LIVER AND WALKER 
256 CARCINOSARCOMA TISSUE
Fractions
No. of 
Animals
Hexosamine 
jimoles per 
g Protein
Gal NH 2  ^
Glu NHg
Liver Tumor Liver Tumor
Whole Homogenate 15 23.6 + 1.2^ 30.3 + 1.0 1:13.8 1:10.1
Nucleus 12 11.2 + 1.4 23.3 +  0.8 1: 5.6 1; 9.4
Mitochondria 15 32.9 + 1.7 48.8 +  1.6 1:20.8 1:13.1
Microsome 15 25.7 + 2.0 37.9 +  1.9 1: 9.3 1: 7.6
Lysosome 15 37.5 + 2.0 53.1 +  1.5 1:16.7 1: 9.4
Soluble Fraction 13 5.9 + 0.4 32.4 +  1.9 _ -c 1:10.8
^Gal NHg: Galactosamine: Glu NH^: Glucosamine as determined
by Spinco amino acid analyzer,
^Value following +  signs are standard error of mean.
^The values are too small to be determined accurately.
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system consisting n-butanol— pyridine— 0.1 N HCl (5:3:2). As shown in 
Figure 12, galactose and mannose are distributed throughout the various 
fractions. A v e r y  small amount of fucose is also found in most of the 
fractions. A. larger amount of glucose was found in most of the liver 
subcellular fractions (Figure 12B) . This is probably due to the presence 
of glycogen. In the Walker tumor (Figure 12A), the glucose content is 
relatively low, except for the soluble and nuclear fractions. The high
quantities of glucose found in the soluble fractions may also be due to
the glycogen; however, this problem requires further investigation.
A  careful examination of Figure 12B shows that mitochondrial, 
lysosomal, and microsomal fractions of the rat liver contain greater
amounts of mannose than galactose, whereas this difference is not as
prominent in the subcellular fractions of the Walker tumor (Figure 12A).
Since the difference in the paper chromatograms of the subcel­
lular fractions of the rat liver and the Walker tumor was so striking, 
a quantitative analysis of mannose and galactose was made as the method 
described in page 17 and shown in Table 11. The galactose content in 
the subcellular fractions of the Walker tumor is definitely higher than 
in the corresponding fractions of liver. In the liver, the lysosomal 
fraction is highest in both galactose and mannose content. The ga­
lactose contents of the mitochondrial, microsomal, and nuclear frac­
tions are not strikingly different; however, the soluble fraction is 
low in this sugar. The mitochondria and microsomes contain relatively 
large amounts of mannose, while the nuclear and soluble fractions have 
smaller amounts of this sugar. The mannose content of mitochondrial, 
microsomal, and lysosomal fractions of the liver is more than 3 times
60
SUP NU Ml lY MT
Figure 12A.— Paper chromatogram of neutral sugars found in the 
subcellular fractions of Walker 256 tumor after hydrolysis with 1 N HCl 
at 100° for 6 hrs.
S, mixture of standards; RI, D-ribose; FU, L-fucose;
MN, D-mannose; GL, D-glucose; GA, D-galactose;
GB, galactobiose; NU, nucleus; MI, microsome;
SUP, Soluble fraction; LY, lysosome; MT, mitochondria.
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Figure 12B.-~Paper chromatogram of neutral sugars found in the 
subcellular fractions of rat liver after hydrolysis with 1 N HCl at 100° 
for 6 hrs.
S, Mixture of standards; RI, D-ribose; FU,
MN, D-mannose; GL, D-glucose; GA,
L-fucose;
D-galactose;
GB, galactobiose;
SUP, soluble fraction;
NU, nucleus; 
LY, lysosome;
MI, microsome;
MT, mitochondria.
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TABLE 11
DISTRIBUTION OF NEUTRAL SUGARS IN THE SUBCELLULAR 
FRACTIONS OF NORMAL RAT LIVER AND WALKER 
256 CARCINOSARCOMA TISSUE^
Fractions
D-galac­
tose
(lamoles/g
Protein)
D-Man­
nose 
(|j.moles/g 
Protein)
Ratio D “
Galactose:
D-Mannose
Fucose
(^g/g
Protein)
Liver
Whole homogenate 8.4 28.4 1:3:4
b
Mitochondria 6.0 23.1 1:3.8 1.7
Microsome 9.8 30.4 1:3.1 2.3
Lysosome 13.7 44.1 1:3.2 2.4
Nucleus 4.4 6.7 1:1.5 1.2
Soluble 2.9 4.8 1:1.7 0.7
Walker Tumor
Whole homogenate 16.9 27.4 1:1.6 _ _b
Mitochondria 12.9 16.7 1:1.3 4.8
Microsome 19.3 34.4 1:1.8 3.6
Lysosome 20.3 46.3 1:2.3 2.7
Nucleus 7.9 14.5 1:1.8 3.2
Soluble 18.0 21.2 1:1.2 2.5
^ e a n  of 3 determinations.
’Not determined.
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greater than that of galactose. In the Walker tumor, only the nucleus 
is low in galactose. There are only a little difference in the distri­
bution of galactose in the remainder of the fractions. Although the 
mannose content is also higher than that of galactose throughout all of 
the fractions, the difference is less striking than that found in the 
liver. As the detection of more mannose than galactose in the subcel­
lular fractions might be due to the differences in destruction rate 
during the acid hydrolysis, this matter was carefully evaluated. When 
20 mg each of mannose and galactose were hydrolyzed with 200 mg of 
crystalline bovine albumin under the conditions described above for the 
hydrolysis of subcellular fractions, the recovery of both sugars was 
75-80%. The fact that there was little difference between the recovery 
of mannose and galactose suggests that the presence of more mannose 
than galactose is not due to an artifact. The fucose content in both 
the Walker tumor and the rat liver is low compared with other neutral 
sugars; however, the Walker tumor fractions contain more fucose than 
those of the liver. In the liver, the microsomal and lysosomal frac­
tions are highest in fucose; however, in the Walker tumor, the mito­
chondrial and lysosomal fractions are richest in this sugar. As noted 
in Table 10, subcellular fractions of both liver and tumor are rela­
tively high in hexosamine. Whether hexosamine is present along with 
uronic acid, as in the case of acid mucopolysaccharides, was considered. 
The result of uronic acid analysis indicated that the subcellular frac­
tions of both liver and Walker tumor did contain a very small amount of 
uronic acid. However, its concentration was too small to be determined 
accurately with available techniques.
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- - Immunoelectrophoresis of Deoxycholate Soluble
Fraction of Rat Liver Microsomes
Immunoelectrophoresis is an analytic procedure originally des­
cribed by Grabar and Williams (89) in 1953. Since then modifications 
have been introduced by many investigators. Most immunoelectrophoretic 
tests employ the double diffusion technique in conjunction with electro­
phoretic separation of one of the reactants which precedes the antigen- 
antibody fraction-indicating reaction. Antigen-antibody precipitation 
is the result of specific and firm, but partially or totally reversible 
combination of the two reactants in which entire reactant molecules or 
fragments of them may combine, apparently at their respective surfaces 
without chemical change of antigen or antibody. This reaction is con­
sidered to be the most sensitive and specific reaction for the presence 
of a protein. Studies mentioned in the previous sections, revealed that 
the deoxycholate soluble fraction of rat liver microsomes is apparently 
very active in incorporation of D-glucosamine-l-C-14 into glycoprotein.
If the synthesized glycoprotein is related to serum glycoprotein, it 
should be possible to find a precipitate reaction between the specific 
anti-rat. serum antibodies and the newly synthesized serum protein or 
its precursor in the deoxycholate soluble fraction prepared from rat 
liver microsomes. In order to identify whether the precipitated or any 
other band in immunoelectrophoresis is a glycoprotein, the most sensi­
tive and accurate method is to label the deoxycholate soluble fraction 
with D-glucosamine-l-C-14 and detect the radioactivity in the precipi­
tated band by autoradiographic technique. For this purpose, a microsomal 
deoxycholate soluble fraction was prepared at 90 minutes after intra­
venous injection of 20 pc of D-glucosamine-l-C-14 according to the pro­
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cedure described on page 13. After the microsomes were treated with
0.5% freshly prepared sodium deoxycholate solution, the centrifuged 
supernatant was concentrated 20 times with glass suction ultrafiltra­
tion apparatus from the Carl Schleicher & Schuell Co. The concentrated 
material was then applied on agar slides made from Difco Special Agar 
Noble for electrophoresis. Electrophoresis of this substance was ac­
complished in an LKB Electrophoresis Apparatus 3276BN with Veronal 
buffer at pH 8.6, ionic strength 0.1, at 250 volts for one hour. After 
electrophoresis, the slides were then removed from the electrophoresis 
apparatus and a central trough was made on the slide by means of a gel 
knife. One hundred microliters of anti-rat serum from a rabbit was 
deposited in the central trough and the slides were left for incubation 
at room temperature for 48 hours. At the end of incubation, the un­
precipitated protein was rinsed out with three washes: first, with 1% 
NaCl for 6 hours; second, with 1% NaCl for 16 hours; and third, with 
distilled water for one hour. The slides after being washed and air- 
dried were stained with amido black lOB. The result of immunoelectro­
phoresis is presented in Figure 13A. The deoxycholate soluble fraction 
from rat liver microsome, at the left hand side, has two to three pre­
cipitated bands. The serum from the same animal, at the right hand 
side, shows many precipitated bands. The autoradiograms of those slides 
were made by fixing the slides on Kodak Royal Ortho sheet-film with 
direct contact of emulsion side and agar surface for 8 weeks. The 
resulting autoradiogram is shown in Figure 13B. When Figures 13A. and 
B are compared it is found that, in the deoxycholate soluble fraction, 
band 1 which migrated at the rate of serum albumin in electrophoresis 
has no detectable radioactivity. Therefore, band 1 may be albumin.
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Figure 13— (A) Immunoelectrophoresis:
Right, deoxycholate soluble material; Left, rat whole serum.
(B) Autoradiogram of (A):
Right, rat whole serum; Left, deoxycholate soluble material. 
D-Glucosamine-l-C-14 was used as a tracer.
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Band 2 was a very diffuse band with certain amounts of radioactivity. 
Because of the diffused picture, it was difficult to conclude that band 
2 was an antigen-antibody reacting band. Band 3 was a rather sharp and 
definite band with certain amount of radioactivity. With careful exami­
nation of both the electrophoretic pattern and the autoradiogram of 
whole serum, it was not possible to find any band derived from the whole 
serum corresponding to the band 3 in deoxycholate soluble fraction. On 
the autoradiogram of whole serum, it appeared that most of the radio­
active bands were in the Ct-globulin region although it was impossible to 
name them individually from this picture. Only a few radioactive bands 
were in the p and y globulin region. Albumin and prealbumin had no de­
tectable radioactivity under this experimental condition. In a previous 
section it was concluded that the deoxycholate soluble fraction of liver 
microsomes is the site of incorporation of D-glucosamine-l-C-14 into 
glycoportein, but in the immunological study, the deoxycholate soluble 
fraction showed only two or three bands without any correspondence to 
the bands from whole serum under the same condition. This result sug­
gests that the deoxycholate soluble fraction of liver microsome may syn­
thesize the glycoprotein which is not the direct precursor of the serum 
glycoprotein. In other words, biosynthesis of serum glycoprotein may 
involve a more complicated procedure in which part of the serum glyco­
protein molecules is synthesized in the deoxycholate soluble fraction of 
liver microsomes and as these molecules are released to the serum more 
reactions occur which convert the molecules to the circulating glyco­
protein.
CHAPTER V
DISCUSSION
As indicated earlier, it is well established that the level 
of serum glycoprotein is greatly increased in a variety of pathological 
conditions (3,4,5). However, the significance and cause of this elevation 
are still unknown. Considerable indirect evidence has been accuramulated 
to implicate that the liver is the major site for the biosynthesis of serum 
glycoproteins. Werner (16) and Greenspan et al. (17,18,19,20,21) have 
provided indirect evidence that the liver is the site of serum glycopro­
tein synthesis by demonstrating decreased levels of serum glycoprotein in 
patients with liver disease or in subjects having chemically damaged livers. 
However, this sort of evidence will not explain whether the decrease in serum 
glycoprotein in either liver disease or chemically poisoned liver is due to 
a decreased rate of protein synthesis, which diminishes the synthesis of 
serum glycoprotein or whether it is due to the decrease in the synthesis of 
oligosaccharide chains or due to a decrease in the synthesis of peptide 
moiety as well as oligosaccharide moiety. Moreover, whether the biosynthesis 
of polypeptide and oligosaccharide moieties takes place simultaneously in 
the same place or not is still unknown. Spiro (23) and Shetlar et a l . (25, 
26) presented evidence that specific-activity-time-curves for liver and 
serum glucosamine meet the criteria for the precursor-product relationship 
as formulated by Zilversmit et al. (76) and suggested that liver.is the site
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of synthesis of serum glycoprotein. The results presented in Figure 1, 
show that hepatectomized rats failed to incorporate D-glucosamine-l-C-14 
into serum protein while intact rats incorporate the radioactivity rather 
rapidly into serum protein. These results provide a further evidence that 
the liver is the major site for the biosynthesis of serum glycoprotein. 
Similar results have been observed by Macbeth £t al. (38). Athineos, 
Kukral and Winzler (37) reported that when D-glucosamine-l-C-14 was admin­
istered to the intact and hepatectomized dogs, the Q^-acid glycoprotein of 
the intact dog serum was highly labeled with almost all of the radio­
activity present in glucosamine. However, the identical glycoprotein 
isolated from hepatectomized dogs showed no radioactivity. They conclud­
ed that the liver is the sole site of biosynthesis of this glycoprotein. 
The results obtained from hepatectomized rats also agree with those of 
Sarcione (30) who demonstrated the production of Q^-acid glycoprotein by 
the perfused rat liver.
When radioactivity associated with subcellular fractions of 
rat liver was measured at various time intervals after injection of D- 
glucosamine-l-C-14, radioactivity was found to be rapidly incorporated 
into the microsomal fraction of rat liver (Figure 2). The radioactivity 
in the microsomal fraction reached its peak at two hours after the injec­
tion of radioactive glucosamine. Robinson, Molnar and Winzler (32) and 
Macbeth et al. (38) also reported similar findings, but their results 
showed that the radioactivity associated with the microsomal fraction 
reached its peak at one hour after the administration of radioactive 
glucosamine. The difference could be due to two reasons: (1) the animals 
used in this experiment were fasted for 24 hours before the experiments 
to reduce the contamination of the microsomal fraction by liver glycogen.
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Winzler's group and Macbeth's group all gave food and water to the animals 
ad libitum before and after the administration of the radioactive tracer.
(2) The animals in this experiment were anesthetized with Nembutal be­
fore the injection of the isotopes. The anesthesia usually lasted one to 
two hours. Winzler's group used ether anesthesia which only lasted for 
10 minutes and Macbethe's group injected the isotope intraperitoneally in­
to the animal without anesthesia. It is conceivable that both fasting and 
anesthesia would retard the metabolic processes, but the overall figure of 
the incorporation of D-glucosamin-l-C-l4 would not be altered.
When the time courses of the incorporation of D-glucosamine- 
l-C-14 into subcellular fractions were compared with that of L-leucine- 
l-C-14, it was found that L-leucine-l-C-14 was incorporated much faster 
into the microsomal fraction than D-glucosamine-l-C-14. This suggests that 
the polypeptide and oligosaccharide synthesis do not occur at the same time 
in the microsomal fraction, although the synthesis of Q^-acid glycoprotein 
by perfused rat liver suggested that liver cells were able to synthesize 
both carbohydrate and polypeptide moieties of that particular glycoprotein. 
Further fractionation of the microsomal fraction led to the conclusion that 
the site of incorporation of D-glucosamine-l-C-14 into the protein moiety 
is the deoxycholate soluble fraction. In contrast to protein synthesis, 
which takes place on the ribosome (Figure 4), very little radioactivity 
could be found in the ribosomal fraction (deoxycholate insoluble fraction) 
after the administration of D-glucosamine-l-C-14 (Figure 6). The initial 
incorporation of L-leucine-l-C-14 took place in ribosomal protein and then 
progressively appeared in the deoxycholate soluble protein fraction. In 
the case of incorporation of D-glucosamine-l-C-14, the rate of incorporation, 
was slower than that of L-leucine-l-C-14 and almost all of the radioactivity
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was associated with the deoxycholate soluble protein. It is generally 
believed that ribosomes are the initial subcellular site for incorpora­
tion of amino acids into growing peptide chains and that the completed 
peptide chain is then transferred to the deoxycholate soluble fraction 
of the microsomes (63,90,91). The delayed incorporation of D-gluco­
samine-l-C-14 may indicate that the oligosaccharide chain of glycoprotein 
is synthesized after the completion of polypeptide synthesis in the ribo­
somes. The present results, which indicate that deoxycholate soluble 
fraction as the site of incorporation of the glucosamine moiety agreed 
very well with Sarcione's results. Their results indicated that the sub­
cellular site of hexose incorporation by utilizing the isolated rat liver 
(35) and the isolated deoxycholate soluble fraction (92) was also the de­
oxycholate soluble fraction of the microsomes. Molnar, Robinson, and 
Winzler (36), however, found that besides the labelling of deoxycholate 
soluble fraction there was also a definite labeling of the ribosomes when 
D-glucosamine-l-C-14 was used as the tracer. The incorporation of gluco­
samine on ribosome was reported to reach a maximum specific radioactivity 
somewhat earlier than the microsomal membrane. They also reported that 
specific activity of hexosamine was higher in the ribosomes than in the 
membranes. Therefore, it was concluded that both the ribosomes and the 
deoxycholate soluble fraction have the independent incorporation of gluco­
samine into glycoprotein. Cook, Laico and Eyler (41) studied the incor­
poration of amino acids and glucosamine into the smooth and rough endoplasmic 
reticulum of Ehrlich ascites carcinoma cell. They concluded that the bio­
synthesis of glycoprotein took place at the microsomes in two steps: First,
the polypeptide was synthesized at the polysome, and then the polypeptide 
was linked by carbohydrate within the membranous complex. Sinohara and
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Sky-Peak (40) attempted to isolate s-RNA capable of transferring gluco- 
samine-amino acid vitro or vivo but were unsuccessful. They also 
found that glucosamine was incorporated into the deoxycholate soluble 
fraction of the microsomes and suggested that the carbohydrate moiety of 
glycoprotein was attached to the peptide after the completion of the 
polypeptide chain but before it was released to the cytoplasm.
The fact that glycoprotein is synthesized in the subcellular 
particle indicates that subcellular particles might contain glycoprotein. 
Generally, lysosomal, microsomal and mitochondrial fractions have a higher 
content of bound carbohydrate, including hexosamine, sialic acid, mannose, 
galactose and fucose. Nuclear and soluble fractions have a relatively low 
sugar content. Among those fractions examined, the lysosomal fraction is 
richest in carbohydrate. This finding is in agreement with the results of 
Novikoff's histochemical study (54). He demonstrated that the lysosomal 
particle gave the strongest periodate-schiff stain, and suggested that the 
substances responding to this stain are glycoprotein in nature. When the 
carbohydrate content of Walker tumor and that of rat liver are compared, 
the subcellular fractions of Walker tumor are generally richer in carbo­
hydrate. The Walker 256 tumor might be the source of the extra glycopro­
tein increased in the rats bearing this tumor. In regard to the release 
of glycoprotein by tissues, the vitro incubated medium from the experi­
ment reported in Table 3 was also analyzed for protein bound radioactivity. 
The medium was subjected to paper electrophoresis and the protein-bound 
radioactivity measured with a low background counter. Only a trace of 
radioactivity was found in the O^-globulin fraction. The experiment con­
cerned with release of glycoprotein by the tissues is inconclusive because
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only a trace of radioactivity was found. The tissue itself under these 
conditions, incorporated only one tenth to one twentieth of the radioactive 
ity incorporated by the in vivo system in the same length of time, it is 
not surprising that very little protein-bound radioactivity was found in 
the medium.
After establishing that the major site of the incorporation 
of D-glucosamine-l-C-14 is the deoxycholate soluble fraction of liver 
microsomes the question arises as to how the glucosamine is linked to the 
protein in the microsomal membranes. The most direct approach to this ques­
tion would appear to be to isolate the glycopeptide from the deoxycholate 
soluble fraction of the liver microsome, and to observe the nature of the 
linkage between the carbohydrate and residual amino acid. The sequential 
arrangement of sugars along this chain could also be determined. The work 
reported in this dissertation describes only a preliminary experiments con’- 
cerned with this question. Pronase was chosen as a proteolytic enzyme, . 
because this enzyme has a very broad substrate specificity and is capable 
of hydrolyzing most of the peptide-bonds in protein. The extent of hydroly­
sis of proteins by pepsin, trypsin, chymotrypsin and any other proteinase is 
limited to 10 to 30 per cent and then almost all the resulting digestion 
products are polypeptide or oligopeptides. The extent of hydrolysis of pro­
teins by Pronase was estimated as 60 to 90 per cent by using casein, oval- . 
bumin and wheat gluten as the substrate (64). After extensive digestion 
of the deoxycholate soluble fraction, about 80% of the material was digested. 
During the proteolysis, no cleavage of the sugar moeity from the glycopep­
tide was noticed as indicated by a constant ratio of neutral sugars to hexo­
samine in glycopeptide I and glycopeptide II. The presence of sialic acid 
in the glycopeptides interfered to some extent with proteolytic digestion
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by Proftase. This interference by sialic acid also occures with other 
enzymes (35) . The carbohydrate analysis of glycopeptide I or glyco­
peptide II showed that the ratio of bound hexoses to glucosamine was 
4.3:1. In n o r m a l  rat serum the ratio of neutral sugars to hexosamine 
is usually between 0.9:1 to 1.3:1 (93). Thus, glycopeptide II has less 
glucosamine relative to the hexoses than does serum protein. This may 
suggest that the glycoprotein synthesized in the deoxycholate soluble 
fraction of the liver microsomes is not a final product. There could 
be more reactions to complete the glycoprotein molecule before the par­
tially completed glycoprotein is transferred from the liver microsomes to 
the blood stream. This concept is also suggested by the immunological 
studies on antigenicity of the deoxycholate soluble protein to the anti­
rat serum antibody. If the deoxycholate soluble fraction of the liver 
microsomes contained the final product of some serum protein, one would 
logically expect to find the same precipitating bands produced by the 
deoxycholate soluble substances and the whole serum. This was not found 
in the immunoelectrophoretic experiment. It is possible that the sodium 
deoxycholate might cause the protein molecule extracted from liver micro- 
some to lose its antigenicity. No work could be found in the literature 
about the effect of sodium deoxycholate on the antigenicity of proteins, 
but many investigations have been published to indicate that enzymes may 
be prepared from the liver microsomes by deoxycholate without an apprecia­
ble change in enzyme activity. In considering the point that both the 
enzyme activity and antigenicity of the protein are determined by the 
special conformation of the protein molecule, it would be hard to explain 
how sodium deoxycholate could destroy the antigenicity of some proteins 
but not decrease the enzyme activity of other proteins.
CHAPTER VI
SUMMARY
Incorporation of D-glucosamine-l-C-14 into the subcellular 
fractions of the rat liver showed a rapid incorporation of radioactivity 
into lysosomal and microsomal fractions. The radioactivity in these two 
fractions reached a plateau at 2 hours after the injection of isotope.
The specific radioactivity of serum protein from the same series of animals 
increased somewhat more slowly and reached the maximum activity at 3 to 4 
hours. On the basis of both the specific radioactivity and the total 
radioactivity, it is suggested that the liver microsomes are most active in 
incorporation of D-glucosamine-l-C-14 into glycoprotein. The experiment 
on hepatectomized rats showed that no appreciable radioactivity was incor­
porated into serum protein in the absence of the liver. This is a further 
evidence that liver is the major site for the biosynthesis of serum glyco­
protein.
The general pattern of incorporation of L-leucine-l-C-14 into 
the subcellular fractions of rat liver was different from, that of D-gluco- 
samine-l-C-14 in two ways. (A) The average rate, in terms of time, of 
incorporation of L-leucine-l-C-14 into the microsomal fraction was much 
more rapid than that of D-glucosamine-l-C-14. (B) Incorporation of L- 
leucine-l-C-14 into the submicrosomal fraction showed a very quick labeling 
and disappearance of the radioactivity in the deoxycholate insoluble frac-
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tion (ribosomal fraction) with a latter increase of radioactivity in the 
deoxycholate soluble fraction. In the case of incorporation of D-glucos- 
amine-l-C-14, most of the radioactivity associated with the microsomes 
was found in the deoxycholate soluble fraction. Very little radioact­
ivity was detected in the ribosomal fraction. This may suggest two steps 
in the biosynthesis of glycoprotein: (1) the synthesis of the protein
moiety by ribosomes and (2) the attachment of D-glucosamine and other 
sugar moiety into the protein by the microsomal membrane.
Incorporation of amino acid and amino sugar into subcellular 
fractions of the Walker 256 tumor was indicated by time courses with 
tumor bearing rats. Slow but progressive incorporation of radioactivity 
into microsomal, mitochondrial and supernatant fractions was observed.
The independent incorporation of the radioactive compound by the tumor 
tissue was shown in the hepatectomized rat bearing Walker tumor i^ vivo 
and tumor slices vitro. When the microsomal fraction of Walker tumor, 
after labelling with D-glucosamine-l-C-14, was further separated into de­
oxycholate soluble and insoluble fractions, it was found that most of the 
radioactivity presented in the microsomes was associated with the deoxy­
cholate soluble fraction.
The nature of the radioactivity after administration of D- 
glucosamine-l-C-14 was examined in microsomal, mitochondrial and superna­
tant fractions. Except for a small percentage of radioactivity converted 
into sialic acid, essentially no alteration of D-glucosamine-l-C-14 had 
occurred under these experimental conditions. The protein-bound radio­
activity expressed as a percentage of total radioactivity associated 
with sialic acid at two hours after the administration of isotope was
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5.57o in mitochondrial, 8.4% in microsomal and 13,0% in supernatant frac­
tions. The radioactivity associated with hexosamine, expressed similarly, 
was 97.5% in mitochondrial, 116.1% in microsomal and 92.0% in supernatant 
fractions.
By means of Pronase digestion, a glycopeptide preparation was 
isolated from the deoxycholate soluble fraction of the rat liver microsomes. 
The yield of this glycopeptide was 0.8% by weight. However, 65.9% of the 
radioactivity associated with the deoxycholate soluble fraction was re­
covered in this glycopeptide. Chemical analysis of this glycopeptide 
showed that it was comprised of 60.6% hexoses, 14.9% glucosamine and 
21.3% amino acids. Among the amino acids, aspartic acid occurred in an 
equimolar amount with glucosamine. Threonine, serine, glutamic acid,
proline and glycine were present in equal molar quantities; each was 
present at about one fourth of the amount of aspartic acid. These re­
sults suggest that aspartic acid is very likely linked to glucosamine 
which is then attached to the rest of the sugar moieties in this glyco­
peptide preparation.
The distribution of protein-bound neutral sugars, hexosamine, 
and sialic acid in the subcellular fractions of the Walker 256 tumor was 
compared with those in the rat liver. The subcellular fractions of the 
Walker 256 tumor contained more bound carbohydrates than did those of the 
liver. The molar ratio of sialic acid to hexosamine and the molar ratio 
of galactosamine to glucosamine were higher in the subcellular fractions 
of the Walker tumor. Mitochondrial, lysosomal, and microsomal fractions 
of the rat liver contained strikingly greater amounts of mannose than of 
galactose; this difference was less marked in the subcellular fractions
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of the Walker tumor. Lysosomal, microsomal, and mitochondrial fractions 
of both tissues were higher in bound carbohydrate constituents, including 
hexosamine, sialic acid, mannose, galactose, and fucose, than were the 
nuclear and soluble fractions.
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